Patents Examined by Paul D. Pyla
-
Patent number: 9920296Abstract: The present invention provides a newly isolated bacterial strain of Paenibacillus, designated Paenibacillus alvei strain TS-15 for use as a biocontrol agent in the inhibition and/or elimination of a human foodborne pathogen, e.g., Salmonella, on a plant or plant organ, e.g., a tomato or tomato plant. Strain TS-15 or mutants thereof may also be used in the control of plant pathogens.Type: GrantFiled: November 20, 2013Date of Patent: March 20, 2018Assignee: The United States of America, as represented by the Secretary, Department of Health & Human ServicInventors: Eric W. Brown, Jie Zheng, Alexander Enurah
-
Patent number: 9891213Abstract: Methods are provided for determining a subject's susceptibility to an allergic reaction upon exposure to an offending allergen.Type: GrantFiled: January 12, 2010Date of Patent: February 13, 2018Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Yael Gernez, Leonore A. Herzenberg, Kari Nadeau, Rabindra Tirouvanziam
-
Patent number: 9834756Abstract: Methods of isolating cellular products, such as pancreatic islets, may be used in diabetes research and therapeutic transplantation. The methods may involve providing a donor tissue having desired cells and undesired cells, perfusing the donor tissue with a perfusion solution, developing edema during perfusion of the donor tissue to form a swelled tissue, and separating the desired cells from undesired cellular material to obtain a cellular product. The methods may also include disrupting the tissue, and separating the desired cells from undesired cellular material to obtain the cellular product. The methods may result in an increased yield of cellular product that retains sufficient functional integrity to be useful as a transplantation resource.Type: GrantFiled: July 15, 2011Date of Patent: December 5, 2017Assignee: LIFELINE SCIENTIFIC, INC.Inventors: Michael J. Taylor, Simona C. Baicu, David Kravitz
-
Patent number: 9821033Abstract: The present specification provides, amongst other things, a method of treating scoliosis comprising delivering a therapeutically acceptable amount of a growth modulator to an epiphyseal growth plate to correct or compensate for disproportionate growth.Type: GrantFiled: February 26, 2010Date of Patent: November 21, 2017Assignee: KIERAN MURPHY LLCInventor: Kieran Murphy
-
Patent number: 9737573Abstract: A purple non-sulfur bacteria useful in preventing and/or ameliorating at least one disease selected from the group consisting of inflammatory diseases, allergic diseases, and autoimmune diseases and having high safety is provided. A preventive and/or ameliorative agent is for at least one disease selected from the group consisting of inflammatory diseases, allergic diseases, and autoimmune diseases and includes at least one of a purple non-sulfur bacteria and a culture material obtained by culturing the purple non-sulfur bacteria. The purple non-sulfur bacteria includes Rhodobacter azotoformans.Type: GrantFiled: July 28, 2014Date of Patent: August 22, 2017Assignee: TFK Co., Ltd.Inventors: Nobuhiro Toda, Yasuhiro Hidaka, Masaaki Ishikawa, Shuichi Kanno
-
Patent number: 9706769Abstract: An organ perfusion apparatus and method monitor, sustain and/or restore viability of organs and preserve organs for storage and/or transport. Other apparatus include an organ transporter, an organ cassette and an organ diagnostic device. The method includes perfusing the organ at hypothermic and/or normothermic temperatures. The methods further include perfusing the organ at hypothermic and/or normothermic temperatures with a second perfusate containing a substance for reacting with the organ. Condition of the organ may be automatically monitored, and the perfusion process can be automatically controlled using a control program.Type: GrantFiled: March 4, 2013Date of Patent: July 18, 2017Assignee: ORGAN RECOVERY SYSTEMS, INCInventors: Michael Taylor, John Brassil
-
Patent number: 9663807Abstract: Systems and methods are disclosed for treating lignocellulosic biomass to be supplied to a fermentation system for production of a fermentation product. The systems and methods comprise pre-treating the biomass into pre-treated biomass and separating the pre-treated biomass into a liquid component comprising sugars and a solids component comprising cellulose and lignin. The systems and methods also comprise treating the solids component of the pre-treated biomass into a treated component. The biomass comprises lignocellulosic material. Treating the solids component comprises application of an enzyme formulation and makeup water to form a slurry. The enzyme formulation comprises a cellulase enzyme. The makeup water includes a clarified thin stillage composition and/or an anaerobic membrane digester effluent composition.Type: GrantFiled: January 18, 2012Date of Patent: May 30, 2017Assignee: POET RESEARCH, INC.Inventors: Neelakantam V. Narendranath, William F. McDonald
-
Patent number: 9657267Abstract: Methods are provided for the ex host maturation of immature germline cells into haploid gametes for restoration of fertility in patients in need thereof.Type: GrantFiled: November 5, 2010Date of Patent: May 23, 2017Assignee: PrimeGen Biotech LLCInventors: Fariborz Izadyar, Johnny Yung-Chiong Chow, Constance Yuen
-
Patent number: 9610066Abstract: Disclosed is a method of collecting cells including the steps of: preparing a processed-bone comprising a bone extracted from a living body, a covering agent and first and second holes, wherein an outer surface of the bone is covered with the covering agent attached to the outer surface of the bone, and the first and second holes penetrate through the covering agent and the outer surface of the bone into the interior of the bone; introducing a liquid into the processed-bone from the first hole; and collecting a cell-containing liquid from the second hole.Type: GrantFiled: May 27, 2015Date of Patent: April 4, 2017Assignee: SYSMEX CORPORATIONInventors: Kenji Akama, Nobuyasu Hori
-
Patent number: 9463263Abstract: The present invention relates to methods for preparing bio scaffolds useful in the repair of tears. More specifically, the invention relates to a method of treating rotator cuff tear in a mammalian subject in need thereof comprising the steps of: (i) selectively expanding tenocytes in vitro in culture medium comprising insulin or a functional derivative and a glucocorticoid or a glucocorticoid-like molecule to produce a culture of expanded tenocytes; (ii) seeding a bioscaffold with said expanded tenocytes to produce a tenocyte seeded bioscaffold; and (iii) implanting said tenocyte seeded bioscaffold proximal to the rotator cuff tear. The present invention also relates to a bioscaffold comprising cells, wherein more than 80% of said cells are tenocytes.Type: GrantFiled: April 24, 2008Date of Patent: October 11, 2016Assignee: Orthocell Pty LtdInventor: Ming-Hao Zheng
-
Patent number: 9441200Abstract: The invention provides compositions and methods for the preparation of biocompatible biomaterials from adipose tissue. Biocompatible biomaterials are cellular or acellular biomaterials. The invention further provides methods of use of the biocompatible biomaterials.Type: GrantFiled: February 11, 2009Date of Patent: September 13, 2016Assignee: THE JOHNS HOPKINS UNIVERSITYInventors: Gedge Rosson, Jennifer H. Elisseeff, Zayna Nahas, Zhaoyang Ye, Alexander Hillel
-
Patent number: 9376697Abstract: A method for on-farm processing a biomass feedstock into a useful industrial chemicals includes the steps of (a) delignifying the biomass feedstock to produce a delignified biomass, (b) subjecting the delignified biomass to cellulase production, (c) subjecting the delignified biomass with attached cellulase to simultaneous cellulolytic and solventogenic reactions to produce useful industrial chemicals (d) collecting and separating the useful industrial chemical from the fermentation broth and (e) collecting the fermentation residues.Type: GrantFiled: October 25, 2013Date of Patent: June 28, 2016Assignee: The University of Kentucky Research FoundationInventors: Sue E. Nokes, Bert C. Lynn, Stephen Rankin, Barbara Knutson, Michael D. Montross, Michael Flythe
-
Patent number: 9249431Abstract: The invention relates to a process for producing organic acids, acid derivatives thereof and/or organic alcohols. In particular, the invention relates to a process for culturing a butyric acid-producing micro-organism in a culture vessel; transferring a portion of the butyric acid which is produced in the culture vessel to a separate compartment; and then reintroducing a portion of the acids from the second compartment in a controlled manner into the culture vessel. The invention also relates to a process for making butanol. The invention further relates to a process for culturing a butyrate-producing micro-organism in a first compartment of an electrochemical reactor, passing a direct current electric field across the electrochemical reactor and harvesting butyric acid or acid derivatives thereof in a second compartment of the reactor. The invention further relates to a process for producing butanol from the butyric acid.Type: GrantFiled: February 27, 2009Date of Patent: February 2, 2016Assignee: Green Biologics LimitedInventors: Edward Green, Matthew Crow
-
Patent number: 9222111Abstract: To provide a method for supplying lauric acid with algae. A method for producing an oil or fat containing lauric acid as a constituent fatty acid including: culturing, in a medium, at least one species of algae in the class Cryptophyceae selected from the group consisting of algae belonging to the genus Rhodomonas and algae belonging to the genus Chroomonas selected from among Chroomonas diplococca, Chroomonas mesostigmatica, Chroomonas nordstedtii, and Chroomonas placoidea and recovering, from the culture product, an oil or fat having a lauric acid content of 3 weight % or higher of the fatty acid composition.Type: GrantFiled: March 24, 2011Date of Patent: December 29, 2015Assignee: Kao CorporationInventors: Hiroshi Yoshida, Fumikazu Takahashi, Yasushi Takimura
-
Patent number: 9109247Abstract: The present invention provides an in vitro method for determining the glycemic index values for various food products. The present invention provides an accurate and inexpensive in vitro method for determining the glycemic index of a wide variety of both food ingredients and finished food products.Type: GrantFiled: June 23, 2008Date of Patent: August 18, 2015Assignee: Intercontinental Great Brands LLCInventors: Robert L. Magaletta, Suzanne N. DiCataldo
-
Patent number: 9101558Abstract: To provide a method of efficiently delivering cells having an anti-tumor activity to tumor tissues to evoke a stronger anti-tumor reaction, and a method of providing a more effective tumor regression effect, both in a cellular immunotherapy for cancer utilizing cells having an anti-tumor activity or antigen presenting cells for activating cells capable of exhibiting an anti-tumor activity. Provided are: a method of treating head and neck cancer, comprising administering an anti-cancer cell composition containing NKT cells activated in vitro with an NKT cell ligand into the tumor-feeding artery, and administering an NKT cell-stimulating agent containing antigen presenting cells treated with an NKT cell ligand through the upper respiratory tract mucous membrane; a use, in anti-cancer treatment of head and neck region, of the anti-cancer cell composition and the NKT cell-stimulating agent; a kit comprising the anti-cancer cell composition and the NKT cell-stimulating agent; and the anti-cancer cell composition.Type: GrantFiled: September 26, 2008Date of Patent: August 11, 2015Assignee: National University Corporation Chiba UniversityInventors: Masaru Taniguchi, Shigetoshi Horiguchi, Yoshitaka Okamoto, Toshinori Nakayama
-
Patent number: 9101566Abstract: The present invention provides dendritic cells (DCs) having reduced inflammatory activity, a method for producing DCs capable of inducing regulatory T cells and regulatory T cells, and substances useful for such a method, wherein the DCs and regulatory T cells are useful for prevention and treatment of immune diseases. The present invention relates to a cereal plant-derived material fermented with a koji microorganism, which is obtained by fermentation thereof with a koji microorganism, or a processed product thereof. Preferably, the fermented product or a processed product thereof comprises 14-dehydroergosterol. According to the present invention, regulatory DCs and regulatory T cells can be induced and the proliferation of inflammatory T cells can be suppressed using plant-derived materials.Type: GrantFiled: June 25, 2010Date of Patent: August 11, 2015Assignee: KIRIN HOLDINGS KABUSHIKI KAISHAInventors: Daisuke Fujiwara, Masaru Kato, Hideki Koizumi, Kumiko Ikado, Yasuhisa Ano
-
Patent number: 9078741Abstract: The present invention provides for methods and devices suitable for producing a transplantable cellular suspension of living tissue suitable for grafting to a patient. In applying the method and/or in using the device, donor tissue is harvested, subjected to a cell dissociation treatment, cells suitable for grafting back to a patient are collected and dispersed in a solution that is suitable for immediate dispersion over the recipient graft site.Type: GrantFiled: September 1, 2011Date of Patent: July 14, 2015Assignee: Avita Medical LimitedInventors: Fiona M. Wood, Marie L. Stoner
-
Patent number: 9074191Abstract: The present invention provides a system and method for culturing a microalgae biofamily to produce lipids. The method includes growing a microalgae biofamily comprises multiple microalgae species in a liquid medium at a first stress level. A portion of the microalgae are exposed to a second stress level and harvested. Lipids are extracted from the harvested portion. Also disclosed is a system for culturing a microalgae biofamily that comprises an enclosed pond containing microalgae in growth medium and having a sloped bottom, at least one photobioreactor positioned above the pond, and a pump circulating the microalgae-containing growth medium between the pond and the at least one photobioreactor.Type: GrantFiled: December 30, 2010Date of Patent: July 7, 2015Inventor: Marcelo Gonzalez Machin
-
Patent number: 9029140Abstract: The present invention provides for methods and devices suitable for producing a transplantable cellular suspension of living tissue suitable for grafting to a patient. In applying the method and/or in using the device, donor tissue is harvested, subjected to a cell dissociation treatment, cells suitable for grafting back to a patient are collected and dispersed in a solution that is suitable for immediate dispersion over the recipient graft site.Type: GrantFiled: February 28, 2011Date of Patent: May 12, 2015Assignee: Avita Medical LimitedInventors: Fiona M. Wood, Marie L. Stoner